• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Reply to 'Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani et al.对索利马尼等人所著《接种BNT162b2新冠疫苗后发生重度寻常型天疱疮》的回复
J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e750-e751. doi: 10.1111/jdv.18302. Epub 2022 Jun 17.
2
Reply to 'development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani F et al.对索利马尼·F等人所著《接种BNT162b2新冠疫苗后发生严重寻常型天疱疮》的回复
J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e976-e978. doi: 10.1111/jdv.18398. Epub 2022 Jul 12.
3
Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2.接种BNT162b2新冠疫苗后发生重症寻常型天疱疮
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e649-e651. doi: 10.1111/jdv.17480. Epub 2021 Jul 12.
4
Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravation.接种 SARS-CoV-2 疫苗后发生寻常型天疱疮：1 例新发，2 例严重恶化。
Dermatol Ther. 2022 May;35(5):e15396. doi: 10.1111/dth.15396. Epub 2022 Mar 15.
5
Intractable pemphigus foliaceus after COVID-19 mRNA vaccination.新冠病毒mRNA疫苗接种后出现的难治性落叶型天疱疮
J Dermatol. 2024 Jul;51(7):e233-e234. doi: 10.1111/1346-8138.17139. Epub 2024 Feb 6.
6
Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac).接种两剂信使核糖核酸疫苗（BNT162b2）和灭活病毒疫苗（科兴新冠疫苗）后发生的结核病
J Infect. 2023 Mar;86(3):256-308. doi: 10.1016/j.jinf.2022.12.016. Epub 2022 Dec 17.
7
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.智利科兴和国药疫苗接种后动态 IgG 血清阳性率：哨点监测研究。
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
8
Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.一种自我扩增 RNA COVID-19 疫苗（ARCT-154）与 BNT162b2 mRNA COVID-19 疫苗加强针的免疫原性和安全性：一项双盲、多中心、随机、对照、3 期、非劣效性试验。
Lancet Infect Dis. 2024 Apr;24(4):351-360. doi: 10.1016/S1473-3099(23)00650-3. Epub 2023 Dec 20.
9
Pemphigus vulgaris with advanced hypopharyngeal and gastric cancer following SARS-CoV-2 vaccination.接种新型冠状病毒疫苗后并发晚期下咽和胃癌的寻常型天疱疮
J Dermatol. 2023 Feb;50(2):e74-e75. doi: 10.1111/1346-8138.16539. Epub 2022 Jul 29.
10
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases.罕见风湿性疾病患者接种BNT162b2 mRNA新冠疫苗后的安全性及疾病复发低风险
J Rheumatol. 2022 Mar;49(3):334-335. doi: 10.3899/jrheum.210863. Epub 2022 Jan 15.

引用本文的文献

1
Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic Review.新型冠状病毒肺炎疫苗接种后的天疱疮和大疱性类天疱疮：一项系统评价
Viruses. 2024 Dec 9;16(12):1896. doi: 10.3390/v16121896.
2
The First Case of Eruptive Pyogenic Granuloma following COVID-19 Vaccination.首例新冠疫苗接种后发生的暴发性化脓性肉芽肿病例。
Case Rep Dermatol. 2024 Jul 15;16(1):190-197. doi: 10.1159/000539849. eCollection 2024 Jan-Dec.
3
Unaddressed Challenges in the Treatment of Cutaneous Melanoma?未解决的皮肤黑素瘤治疗挑战？
Medicina (Kaunas). 2024 May 28;60(6):884. doi: 10.3390/medicina60060884.
4
New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review.新冠疫苗接种后自身免疫性大疱性皮肤病的新发与加重：一项系统评价
Vaccines (Basel). 2024 Apr 26;12(5):465. doi: 10.3390/vaccines12050465.
5
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data.古塞库单抗、司库奇尤单抗和替拉珠单抗治疗化脓性汗腺炎：现有试验及真实世界数据综述
Clin Cosmet Investig Dermatol. 2023 Sep 18;16:2525-2536. doi: 10.2147/CCID.S418748. eCollection 2023.
6
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge.新冠病毒疫苗接种后银屑病的新发与加重：当前知识综述
Biomedicines. 2023 Aug 3;11(8):2191. doi: 10.3390/biomedicines11082191.
7
Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments.甲银屑病：当前可用全身治疗方法的最新综述
Clin Cosmet Investig Dermatol. 2023 Jul 24;16:1899-1932. doi: 10.2147/CCID.S417679. eCollection 2023.
8
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.COVID-19 疫苗接种对炎症性皮肤疾病和其他皮肤疾病的影响：已发表文献综述。
Viruses. 2023 Jun 23;15(7):1423. doi: 10.3390/v15071423.
9
A study of the efficacy and safety of plaque psoriasis treatment by TNF-α and IL-17A inhibitor biologics in patients who received the inactivated SARS-CoV-2 vaccine.一项研究 TNF-α 和 IL-17A 抑制剂生物制剂治疗斑块状银屑病的疗效和安全性，这些患者接受了已灭活的 SARS-CoV-2 疫苗。
Immun Inflamm Dis. 2023 Jul;11(7):e938. doi: 10.1002/iid3.938.
10
Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature.化脓性汗腺炎和 JAK 抑制剂：已发表文献综述。
Medicina (Kaunas). 2023 Apr 20;59(4):801. doi: 10.3390/medicina59040801.

本文引用的文献

1
A Case of Pemphigus Vulgaris and Hidradenitis Suppurativa: May Systemic Steroids Be Considered in the Standard Management of Hidradenitis Suppurativa?一例寻常型天疱疮合并化脓性汗腺炎：在化脓性汗腺炎的标准治疗中是否可考虑使用全身性类固醇？
Skin Appendage Disord. 2022 May;8(3):265-268. doi: 10.1159/000521712. Epub 2022 Jan 26.
2
An Unusual Case of Pemphigus Vulgaris.一例寻常型天疱疮的罕见病例。
Skin Appendage Disord. 2022 Mar;8(2):158-160. doi: 10.1159/000521333. Epub 2022 Jan 11.
3
Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2.接种BNT162b2新冠疫苗后发生重症寻常型天疱疮
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e649-e651. doi: 10.1111/jdv.17480. Epub 2021 Jul 12.
4
Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.出版商更正：COVID-19 RNA疫苗BNT162b1在成人中的I/II期研究。
Nature. 2021 Feb;590(7844):E26. doi: 10.1038/s41586-020-03098-3.
5
COVID-19 vaccine BNT162b1 elicits human antibody and T1 T cell responses.COVID-19 疫苗 BNT162b1 可引发人体抗体和 T1 T 细胞应答。
Nature. 2020 Oct;586(7830):594-599. doi: 10.1038/s41586-020-2814-7. Epub 2020 Sep 30.
6
Exacerbation of pemphigus after influenza vaccination.流感疫苗接种后天疱疮病情加重。
Clin Exp Dermatol. 2008 Nov;33(6):718-20. doi: 10.1111/j.1365-2230.2008.02835.x. Epub 2008 Aug 2.
7
Exacerbation of pemphigus foliaceus after tetanus vaccination accompanied by synthesis of auto-antibodies against paraneoplastic pemphigus antigens.
Acta Derm Venereol. 2002;82(6):482-3. doi: 10.1080/000155502762064755.

Reply to 'Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani et al.

作者信息

Martora F, Fabbrocini G, Nappa P, Megna M

机构信息

Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

出版信息

J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e750-e751. doi: 10.1111/jdv.18302. Epub 2022 Jun 17.

DOI:10.1111/jdv.18302
PMID:35679165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9347809/
Abstract
摘要